Other studies on cervical cancer (Ji et al., 2019; Zhang et al., 2019c), prostate cancer (Luo et al., 2020), osteosarcoma (Hou and Mao, 2020), endometrial cancer (Zhao et al., 2020), retinoblastoma (Sun et al., 2020), clear cell renal cell carcinoma (Liu et al., 2017), diffuse large B cell lymphoma (Zhao L. et al., 2019; Tian et al., 2021), and acute myeloid leukemia (Wang et al., 2021a) indicated a tumor promoter role for SNHG14 through complex molecular mechanisms. The gene discussed is SNHG14; the disease is cervical carcinoma.